Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dopamine Rhythms in Cocaine Addiction
NCT02233829Phase 1Withdrawn
- Sponsor
- National Institute on Alcohol Abuse and Alcoholism
- Start
- Apr 2024
- Primary completion
- Apr 2024
- Countries
- 1
01
Overview
Phase 1, open-label trial of methylphenidate in cocaine use disorder (CUD) (2 arms), sponsored by National Institute on Alcohol Abuse and Alcoholism. Primary endpoint: Disruption in circadian rhythms in cocaine use disorder. Planned start Apr 2024; status: withdrawn.
02
Drugs
methylphenidate
03
Conditions
cocaine use disorder (CUD)
Beyond the preview
Go deeper on NCT02233829.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02233829.